| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/21/2009 | CN100453095C 'Jindan' soft capsule, and its prepn. method |
| 01/21/2009 | CN100453094C Medicine composition of effective parts for compound Tongmai Chinese medicine oral liquid and its preparing method |
| 01/21/2009 | CN100453091C Capsule of purple sweet potato, its production and application |
| 01/21/2009 | CN100453088C Marsdenia tenacissima soft capsule and its preparation method |
| 01/21/2009 | CN100453087C Medicine for treating tuberculosis |
| 01/21/2009 | CN100453086C Gel for removing ocular by ice pearl and its preparation |
| 01/21/2009 | CN100453085C Forest frog's egg fat injection and its preparing process |
| 01/21/2009 | CN100453082C Compound terbinafine and root of large flowered skullcap cream and its preparing method |
| 01/21/2009 | CN100453079C Water-soluble liquid internal medicine |
| 01/21/2009 | CN100453078C Method for treating primary insomnia |
| 01/21/2009 | CN100453077C Injectable micelle prepn containing garcinolic acid and its prepn process |
| 01/21/2009 | CN100453074C Sustained release drug delivery device |
| 01/21/2009 | CN100453073C Compound radical lobelia dripping pill and its preparing method |
| 01/21/2009 | CN100453072C Isatis root drops and preparation thereof |
| 01/21/2009 | CN100453071C Oral resveratrol multi-phase liposome and preparation method thereof |
| 01/21/2009 | CN100453070C Aseptic dry powder spray agent and production method in use for stopping the blood and diminishing inflammation in wound |
| 01/21/2009 | CN100453069C Biphenyl diester emulsion and its preparing method |
| 01/21/2009 | CN100453068C Injection containing caderfloxacin lactate |
| 01/21/2009 | CN100453067C Preparation of injectable suspensions having improved injectabity |
| 01/21/2009 | CN100453066C Drug delivery system using subconjunctival depot |
| 01/21/2009 | CN100452993C Health care food |
| 01/21/2009 | CN100452984C Aimal growth regulating composition and its prepn and use |
| 01/20/2009 | US7480215 Read write device for optical memory and method therefore |
| 01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 01/20/2009 | US7479535 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation |
| 01/20/2009 | US7479530 Comprising one or more macromonomer units selected from perfluoroalkylpolyether, fluorinated poly(meth)acrylate, poly(perfluoroalkyl) (meth)acrylate, poly(fluoroalkyl) (meth)acrylamide, and fluorinated polyolefin, and one or more charged units; intraocular lenses |
| 01/20/2009 | US7479508 Nimesulide containing topical pharmaceutical compositions |
| 01/20/2009 | US7479490 pellets comprising resazurin, anhydrous sodium sulfate, 1-hydroxyethylidene biphosphonate, tetrasodium salt and magnesium stearate |
| 01/20/2009 | US7479483 Tumor-targeted drug delivery systems and uses thereof |
| 01/20/2009 | US7479481 Treatment of ocular diseases and disorders using lantibiotic compositions |
| 01/20/2009 | US7479276 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 01/20/2009 | US7479254 Kit including a cucurbit(6-10)uril derivative bound to a first material; anda second component that is a ligand that non-covalently binds to the cucurbituril bound to a second material; materials include biomolecules, drugs, catalysts, chromophores, fluorescent materials, phosphors, and cyclophanes |
| 01/20/2009 | US7479135 Automatic conveyor driven by hydrogels, provided with an adjustable output characteristic for conveying a medium |
| 01/20/2009 | US7479132 An ionic medicine impregnated into an electrode-free ion-exchange membrane having a surface roughness (Rz) of 1 mu m or less; no application of voltage |
| 01/20/2009 | CA2637874A1 Patch and adhesive preparation |
| 01/20/2009 | CA2586146C Fluorocarbon aerosol medicaments |
| 01/20/2009 | CA2567575C Organo-gel formulations for therapeutic applications |
| 01/20/2009 | CA2517245C Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 01/20/2009 | CA2488651C System and process for releasing encapsulated active ingredients |
| 01/20/2009 | CA2468916C A stable oxaliplatin solution formulation |
| 01/20/2009 | CA2445519C Method for manufacturing a low dose pharmaceutical composition |
| 01/20/2009 | CA2444116C Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 01/20/2009 | CA2432172C An in vivo method for producing female offsprings in mammals |
| 01/20/2009 | CA2411685C Optimised pellet formulations |
| 01/20/2009 | CA2392721C Intervertebral disc treatment devices and methods |
| 01/20/2009 | CA2391613C Injection-moulded water-soluble container |
| 01/20/2009 | CA2383916C Dispersion formulations containing lipase inhibitors |
| 01/20/2009 | CA2383241C Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 01/20/2009 | CA2355644C Controlled/modified release oral methylphenidate formulations |
| 01/20/2009 | CA2352762C Oral transmucosal delivery |
| 01/20/2009 | CA2352483C Pharmaceutical aerosol composition containing hfa 227 and hfa 134a |
| 01/20/2009 | CA2352389C An oral formulation for gastrointestinal drug delivery |
| 01/20/2009 | CA2348759C Gel compositions |
| 01/20/2009 | CA2339193C Pharmaceutical compositions comprising ibuprofen and domperidone |
| 01/20/2009 | CA2338794C New oral formulation for 5-ht4 agonists or antagonists |
| 01/20/2009 | CA2317008C Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
| 01/20/2009 | CA2312795C The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
| 01/20/2009 | CA2305621C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 01/20/2009 | CA2247103C Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 01/20/2009 | CA2246344C A solid non-effervescent compressed dosage form containing racemic ibuprofen |
| 01/20/2009 | CA2213660C Aerosol containing beclamethasone nanoparticle dispersions |
| 01/18/2009 | CA2598948A1 Enhanced formulations of lamotrigine |
| 01/15/2009 | WO2009009665A2 O-desmethylvenlafaxine |
| 01/15/2009 | WO2009009657A2 A composition to impart benefit agents to anionic substrates and methods of its use |
| 01/15/2009 | WO2009009651A1 Dermal delivery device with ultrasonic weld |
| 01/15/2009 | WO2009009649A1 Dermal delivery device with in situ seal |
| 01/15/2009 | WO2009009622A2 Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| 01/15/2009 | WO2009009620A2 Acellular tissue matrix compositions for tissue repair |
| 01/15/2009 | WO2009009562A2 Glp-1-fc fusion protein formulation |
| 01/15/2009 | WO2009009470A1 Stable formulations of thiadiazole derivatiive |
| 01/15/2009 | WO2009009135A1 Compositions for delivering a drug |
| 01/15/2009 | WO2009009134A1 Compositions for delivering a drug |
| 01/15/2009 | WO2009009115A2 Liposome compositions for treatment of hepatitis c |
| 01/15/2009 | WO2009009054A1 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 01/15/2009 | WO2009008946A1 Hydrogel polymeric compositions and methods |
| 01/15/2009 | WO2009008895A1 Pleasant-tasting ranitidine formulation |
| 01/15/2009 | WO2009008873A1 A gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group- containing precursor |
| 01/15/2009 | WO2009008716A1 Method for marking materials |
| 01/15/2009 | WO2009008595A1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 01/15/2009 | WO2009008489A1 Antibody liposome |
| 01/15/2009 | WO2009008487A1 Coated preparation |
| 01/15/2009 | WO2009008391A1 Method of producing microparticles to be ingested into the body, microparticles to be ingested into the body and dispersion and medicinal composition containing the same |
| 01/15/2009 | WO2009008006A2 Pharmaceutical compositions for gastrointestinal drug delivery |
| 01/15/2009 | WO2009008005A1 Pharmaceutical compositions of rifaximin |
| 01/15/2009 | WO2009008004A2 Sustained release formulations of divalproex sodium |
| 01/15/2009 | WO2009007992A2 Pharmaceutical composition produced by microprecipitation |
| 01/15/2009 | WO2009007920A2 Delivery systems for delivering functional compounds to substrates and processes of using the same |
| 01/15/2009 | WO2009007808A1 Combined pharmaceutical composition |
| 01/15/2009 | WO2009007785A2 Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| 01/15/2009 | WO2009007770A1 Chewing gum granules for compressed chewing gum |
| 01/15/2009 | WO2009007769A1 Multi-modular chewing gum tablet |
| 01/15/2009 | WO2009007768A1 Compressed tablet comprising polyol |
| 01/15/2009 | WO2009007767A1 Compressed chewing gum comprising an encapsulation delivery system comprising natural resin |
| 01/15/2009 | WO2009007764A2 Pharmaceutical preparations containing highly volatile silicones |
| 01/15/2009 | WO2009007762A1 Metronidazole containing extended release floating pharmaceutical composition |
| 01/15/2009 | WO2009007687A2 An inhalable medicament |
| 01/15/2009 | WO2009007635A1 Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof |
| 01/15/2009 | WO2009007622A2 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof |
| 01/15/2009 | WO2009007573A2 Method for preparing a granulated form |
| 01/15/2009 | WO2009007426A1 Oral pharmaceutical solutions containing telbivudine |